Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)

Clinical trial NCT00401375 · COMPLETED

Trial details

NCT number: NCT00401375
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Post-Operative Ileus (POI)

Start date: 2006-10-31
Primary completion: 2008-02-29
Enrollment: 524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.